Fiduciary Alliance LLC Acquires Shares of 5,418 Humana Inc. (NYSE:HUM)

Fiduciary Alliance LLC bought a new position in shares of Humana Inc. (NYSE:HUM - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 5,418 shares of the insurance provider's stock, valued at approximately $1,375,000.

Other hedge funds have also modified their holdings of the company. State Street Corp boosted its position in Humana by 1.0% in the 3rd quarter. State Street Corp now owns 5,357,420 shares of the insurance provider's stock valued at $1,701,582,000 after buying an additional 53,272 shares during the last quarter. FMR LLC increased its position in Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider's stock worth $1,073,387,000 after purchasing an additional 643,291 shares during the period. Pzena Investment Management LLC raised its holdings in Humana by 8.1% during the 3rd quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider's stock worth $793,830,000 after purchasing an additional 187,903 shares during the last quarter. Marshall Wace LLP lifted its position in Humana by 118.9% during the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider's stock valued at $532,564,000 after purchasing an additional 774,085 shares during the period. Finally, Legal & General Group Plc lifted its position in Humana by 2.1% during the 2nd quarter. Legal & General Group Plc now owns 1,183,985 shares of the insurance provider's stock valued at $442,396,000 after purchasing an additional 24,842 shares during the period. 92.38% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. Sanford C. Bernstein upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $308.00 price objective on the stock in a report on Tuesday, October 8th. Stephens reissued an "equal weight" rating and issued a $250.00 price target on shares of Humana in a research note on Wednesday, October 9th. Jefferies Financial Group cut Humana from a "buy" rating to a "hold" rating and decreased their price objective for the stock from $519.00 to $253.00 in a research note on Monday, October 7th. Morgan Stanley raised their target price on Humana from $288.00 to $301.00 and gave the stock an "equal weight" rating in a report on Tuesday, December 17th. Finally, UBS Group lowered their price target on Humana from $380.00 to $250.00 and set a "neutral" rating for the company in a research note on Friday, October 4th. Twenty equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Humana presently has an average rating of "Hold" and a consensus target price of $302.00.

Insiders Place Their Bets

In other news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company's stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.32% of the company's stock.

Humana Stock Down 1.7 %

Shares of NYSE HUM traded down $4.79 during mid-day trading on Tuesday, hitting $282.57. The company had a trading volume of 998,337 shares, compared to its average volume of 1,313,264. Humana Inc. has a one year low of $213.31 and a one year high of $455.53. The company has a market capitalization of $34.02 billion, a PE ratio of 25.03, a price-to-earnings-growth ratio of 2.12 and a beta of 0.55. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The firm has a 50-day simple moving average of $273.89 and a two-hundred day simple moving average of $309.74.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to analysts' expectations of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. On average, equities analysts expect that Humana Inc. will post 16.14 EPS for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.25%. The ex-dividend date is Tuesday, December 31st. Humana's payout ratio is currently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.